J. Węsierska-Gądek

发表

Differential susceptibility of normal and PARP knock‐out mouse fibroblasts to proteasome inhibitors

Z. Herceg, Zhao-Qi Wang, J. Węsierska‐Gądek, 2000, Journal of cellular biochemistry.

Advances in Brief Reduced Stability of Regularly Spliced but not Alternatively Spliced p 53 Protein in PARP-deficient Mouse Fibroblasts 1

Zhao-Qi Wang, J. Węsierska‐Gądek, G. Schmid, 1998 .

Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis

J. Węsierska‐Gądek, E. Hitchman, E. Penner, 2006, Hepatology.

Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis.

J. Węsierska‐Gądek, E. Hitchman, E. Penner, 2001, Journal of hepatology.

Novel potent pharmacological cyclin-dependent kinase inhibitors.

J. Węsierska‐Gądek, V. Kryštof, Ivo Chamrád, 2009, Future medicinal chemistry.

Differential Potential of Pharmacological PARP Inhibitors for Inhibiting Cell Proliferation and Inducing Apoptosis in Human Breast Cancer Cells

J. Węsierska‐Gądek, G. Mitulovič, Matthias Mauritz, 2015, Journal of cellular biochemistry.

Synergistic Effects of Erlotinib and Everolimus on Bronchial Carcinoids and Large-Cell Neuroendocrine Carcinomas with Activated EGFR/AKT/mTOR Pathway

C. Pirker, W. Berger, Z. Bago-Horvath, 2012, Neuroendocrinology.

A new, unexpected action of olomoucine, a CDK inhibitor, on normal human cells: Up‐regulation of CLIMP‐63, a cytoskeleton‐linking membrane protein

B. Sarg, H. Lindner, J. Węsierska‐Gądek, 2007, Journal of cellular biochemistry.

Interference with ER‐α enhances the therapeutic efficacy of the selective CDK inhibitor roscovitine towards ER‐positive breast cancer cells

J. Węsierska‐Gądek, O. Komina, M. Maurer, 2011, Journal of cellular biochemistry.

The impact of multi-targeted cyclin-dependent kinase inhibition in breast cancer cells: clinical implications

J. Węsierska‐Gądek, M. Kramer, J. Węsierska-Gądek, 2011, Expert opinion on investigational drugs.

Resveratrol modulates roscovitine-mediated cell cycle arrest of human MCF-7 breast cancer cells.

J. Węsierska‐Gądek, M. Kramer, M. Maurer, 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

Lifestyle and individual risk of contracting neoplastic disease: facts and myths concerning the aetiology of cancer

J. Węsierska‐Gądek, J. Węsierska-Gądek, 2019 .

Nuclear architecture and ultrastructural distribution of poly(ADP-ribosyl)transferase, a multifunctional enzyme.

J. Węsierska‐Gądek, E. Penner, P. Hozák, 1996, Journal of cell science.

Modification of nuclear matrix proteins by ADP-ribosylation. Association of nuclear ADP-ribosyltransferase with the nuclear matrix.

J. Węsierska‐Gądek, G. Sauermann, J. Węsierska-Gądek, 1985, European journal of biochemistry.

Whether to target single or multiple CDKs for therapy? That is the question

J. Węsierska‐Gądek, O. Komina, M. Maurer, 2011, Journal of cellular physiology.

The subcellular distribution of the p53 tumour suppressor, and organismal ageing.

J. Węsierska‐Gądek, G. Schmid, J. Węsierska-Gądek, 2005, Cellular & molecular biology letters.

Phenol red in the culture medium strongly affects the susceptibility of human MCF-7 cells to roscovitine

J. Węsierska‐Gądek, M. Maurer, Tanja Schreiner, 2007, Cellular & Molecular Biology Letters.

Endocrine disruptor contaminants in water and their adverse effects in humans

J. Węsierska‐Gądek, J. Węsierska-Gądek, 2006 .

mTOR and its link to the picture of Dorian Gray - re-activation of mTOR promotes aging

J. Węsierska‐Gądek, J. Węsierska-Gądek, 2010, Aging.

Cellular and organismal ageing: Role of the p53 tumor suppressor protein in the induction of transient and terminal senescence

J. Węsierska‐Gądek, G. Schmid, M. Kramer, 2007, Journal of cellular biochemistry.

The impact of CDK inhibition in human malignancies associated with pronounced defects in apoptosis: advantages of multi-targeting small molecules.

J. Węsierska‐Gądek, M. Kramer, J. Węsierska-Gądek, 2012, Future medicinal chemistry.

Signaling of DNA damage is not sufficient to induce p53 response: (Re)Activation of wt p53 protein strongly depends on cellular context

J. Węsierska‐Gądek, G. Schmid, M. Kramer, 2008, Journal of cellular biochemistry.

Effect of Distinct Anticancer Drugs on the Phosphorylation of p53 Protein at Serine 46 in Human MCF‐7 Breast Cancer Cells

J. Węsierska‐Gądek, M. Gueorguieva, I. Herbacek, 2007, Annals of the New York Academy of Sciences.

Prevention of p53 Degradation in Human MCF‐7 Cells by Proteasome Inhibitors Does Not Mimic the Action of Roscovitine

J. Węsierska‐Gądek, M. Gueorguieva, C. Ranftler, 2006, Annals of the New York Academy of Sciences.

Dual action of the inhibitors of cyclin-dependent kinases: targeting of the cell-cycle progression and activation of wild-type p53 protein

J. Węsierska‐Gądek, G. Schmid, J. Węsierska-Gądek, 2006, Expert opinion on investigational drugs.

How the Nucleolar Sequestration of p53 Protein or Its Interplayers Contributes to Its (Re)‐Activation

J. Węsierska‐Gądek, Marcel Horkya, J. Węsierska-Gądek, 2003 .

Phosphorylation regulates the interaction and complex formation between wt p53 protein and PARP‐1

J. Węsierska‐Gądek, G. Schmid, J. Wojciechowski, 2003, Journal of cellular biochemistry.

Central and carboxy‐terminal regions of human p53 protein are essential for interaction and complex formation with PARP‐1

J. Węsierska‐Gądek, G. Schmid, J. Wojciechowski, 2003, Journal of cellular biochemistry.

Escape of p53 protein from E6‐mediated degradation in HeLa cells after cisplatin therapy

J. Węsierska‐Gądek, M. Horký, V. Kotala, 2002, International journal of cancer.

Advantage of a baculovirus expression system for protein-protein interaction studies. Involvement of posttranslational phosphorylation in the interaction between wt p53 protein and poly(ADP-ribose) polymerase-1.

J. Węsierska‐Gądek, G. Schmid, J. Wojciechowski, 2005, Acta biochimica Polonica.

Poly(ADP-ribose) polymerase-1 regulates the stability of the wild-type p53 protein.

J. Węsierska‐Gądek, G. Schmid, J. Węsierska-Gądek, 2001, Cellular & molecular biology letters.

Overexpressed poly(ADP‐ribose) polymerase delays the release of rat cells from p53‐mediated G1 checkpoint

J. Węsierska‐Gądek, G. Schmid, J. Węsierska-Gądek, 2000, Journal of cellular biochemistry.

Antibodies to nuclear lamin C in chronic hepatitis delta virus infection

J. Węsierska‐Gądek, E. Hitchman, E. Penner, 1990, Hepatology.

Major contribution of the multidrug transporter P‐glycoprotein to reduced susceptibility of poly(ADP‐ribose) polymerase‐1 knock‐out cells to doxorubicin action

J. Węsierska‐Gądek, J. Węsierska-Gądek, 2005, Journal of cellular biochemistry.

Increased resistance to anticancer therapy of mouse cells lacking the poly(ADP-ribose) polymerase attributable to up-regulation of the multidrug resistance gene product P-glycoprotein.

Z. Herceg, J. Węsierska‐Gądek, G. Wurzer, 2000, Cancer research.

ADP‐ribosylation of nucleolar proteins in HeLa tumor cells

J. Węsierska‐Gądek, N. Leitinger, J. Węsierska-Gądek, 1993, Journal of cellular biochemistry.

Nucleolus and Apoptosis

J. Węsierska‐Gądek, M. Horký, V. Kotala, 2002, Annals of the New York Academy of Sciences.

Outcome of treatment of human HeLa cervical cancer cells with roscovitine strongly depends on the dosage and cell cycle status prior to the treatment

J. Węsierska‐Gądek, E. Walzi, O. Komina, 2009, Journal of cellular biochemistry.

Rapid onset of nucleolar disintegration preceding cell cycle arrest in roscovitine‐induced apoptosis of human MCF‐7 breast cancer cells

J. Węsierska‐Gądek, M. Gueorguieva, M. Horký, 2003, International journal of cancer.

Roscovitine, a small molecule CDK inhibitor induces apoptosis in multidrug-resistant human multiple myeloma cells.

J. Węsierska‐Gądek, M. Maurer, O. Komina, 2011, Journal of experimental therapeutics & oncology.

Selective Cyclin‐Dependent Kinase Inhibitors Discriminating between Cell Cycle and Transcriptional Kinases

J. Węsierska‐Gądek, V. Kryštof, J. Węsierska-Gądek, 2009, Annals of the New York Academy of Sciences.

Autoantibodies in chronic GVHD: high prevalence of antinucleolar antibodies.

J. Węsierska‐Gądek, S. Bakos, E. Penner, 1990, Bone marrow transplantation.

Roscovitine up‐regulates p53 protein and induces apoptosis in human HeLaS3 cervix carcinoma cells

J. Węsierska‐Gądek, M. Kramer, V. Kryštof, 2008, Journal of cellular biochemistry.

Characterization of the antibodies to p62 nucleoporin in primary biliary cirrhosis using human recombinant antigen

J. Węsierska‐Gądek, O. Komina, J. Hanover, 2008, Journal of cellular biochemistry.

Inhibition of farnesyl protein transferase sensitizes human MCF‐7 breast cancer cells to roscovitine‐mediated cell cycle arrest

J. Węsierska‐Gądek, G. Schmid, M. Maurer, 2007, Journal of cellular biochemistry.

Characterization of Autoantibodies against Components of the Nuclear Pore Complexes

J. Węsierska‐Gądek, O. Komina, E. Penner, 2007, Annals of the New York Academy of Sciences.

Segregation of nucleolar components coincides with caspase-3 activation in cisplatin-treated HeLa cells.

J. Węsierska‐Gądek, B. Vojtesek, M. Horký, 2001, Journal of cell science.

Autoimmune cholangitis and primary biliary cirrhosis--an autoimmune enigma.

I. Mackay, J. Węsierska‐Gądek, Y. Nakanuma, 1999, Liver.

Members of the glutathione S-transferase gene family are antigens in autoimmune hepatitis.

J. Węsierska‐Gądek, E. Hitchman, E. Penner, 1998, Gastroenterology.

Reactivity of autoimmune hepatitis sera with glutathione S-transferase

J. Węsierska‐Gądek, E. Penner, J. Węsierska-Gądek, 2000 .

Nucleolar proteins B23 and C23 as target antigens in chronic graft-versus-host disease.

J. Węsierska‐Gądek, E. Hitchman, E. Penner, 1992, Blood.

Phenol red reduces ROSC mediated cell cycle arrest and apoptosis in human MCF‐7 cells

J. Węsierska‐Gądek, M. Gueorguieva, Tanja Schreiner, 2006, Journal of cellular biochemistry.

Autoantibodies against nucleoporin p62 constitute a novel marker of primary biliary cirrhosis.

J. Węsierska‐Gądek, E. Hitchman, E. Penner, 1996, Gastroenterology.

Antibodies to nuclear lamins in autoimmune liver disease.

J. Węsierska‐Gądek, E. Hitchman, E. Penner, 1988, Clinical immunology and immunopathology.

Anti-gp210 antibodies in sera of patients with primary biliary cirrhosis. Identification of a 64 kD fragment of gp210 as a major epitope.

E. Hitchman, E. Penner, H. Hohenauer, 1996, Human antibodies and hybridomas.

Autoantibodies against constituents of nuclear pore complexes in patients with primary biliary cirrhosis and autoimmune hepatitis.

E. Hitchman, E. Penner, H. Hohenauer, 1995, Acta biochimica Polonica.

544 Prognostic value of autoantibodies against proteins of nuclear pore complexes (anti-NPCS) in early primary biliary cirrhosis (PBC)

J. Węsierska‐Gądek, E. Hitchman, E. Penner, 2004 .

Increased Susceptibility of Poly(ADP-Ribose) Polymerase-1 Knockout Cells to Antitumor Triazoloacridone C-1305 Is Associated with Permanent G2 Cell Cycle Arrest

J. Węsierska‐Gądek, M. Gueorguieva, A. Składanowski, 2004, Cancer Research.

A combined treatment of HeLa cells with the farnesyl protein transferase inhibitor L‐744,832 and cisplatin significantly increases the therapeutic effect as compared to cisplatin monotherapy

J. Węsierska‐Gądek, G. Schmid, M. Kramer, 2008, Journal of cellular biochemistry.

[New face of antiapoptotic proteins. II. Survivin].

Z. Kiliańska, Jolanta Bednarek, J. Węsierska-Gądek, 2007, Postepy biochemii.

[New face of antiapoptotic proteins. I. Protein Mcl-1].

Z. Kiliańska, Jolanta Bednarek, J. Węsierska-Gądek, 2007, Postepy biochemii.

Roscovitine, a selective CDK inhibitor, reduces the basal and estrogen‐induced phosphorylation of ER‐α in human ER‐positive breast cancer cells

J. Węsierska‐Gądek, O. Komina, M. Maurer, 2011, Journal of cellular biochemistry.

Therapeutic intervention by the simultaneous inhibition of DNA repair and type I or type II DNA topoisomerases: one strategy, many outcomes.

J. Węsierska‐Gądek, A. Składanowski, J. Węsierska-Gądek, 2012, Future medicinal chemistry.

Roscovitine-induced up-regulation of p53AIP1 protein precedes the onset of apoptosis in human MCF-7 breast cancer cells.

J. Węsierska‐Gądek, M. Gueorguieva, M. Horký, 2005, Molecular cancer therapeutics.

ADP‐ribosylation of p53 tumor suppressor protein: Mutant but not wild‐type p53 is modified

J. Węsierska‐Gądek, A. Bugajska-Schretter, C. Cerni, 1996, Journal of cellular biochemistry.

Fibronectin observed in the nuclear matrix of HeLa tumour cells.

J. Węsierska‐Gądek, G. Zerlauth, G. Sauermann, 1988, Journal of cell science.

Targeting p53 as a promising therapeutic option for cancer by re-activating the wt or mutant p53's tumor suppression.

J. Węsierska‐Gądek, J. Węsierska-Gądek, 2018, Future medicinal chemistry.

p53‐mediated regulation of cell cycle progression: Pronounced impact of cellular microenvironment

J. Węsierska‐Gądek, G. Schmid, M. Kramer, 2009, Journal of cellular physiology.

Strong induction of p73 protein in vivo coincides with the onset of apoptosis in rat liver after treatment with the hepatocarcinogen N‐nitrosomorpholine (NNM)

J. Węsierska‐Gądek, Slavica Tudzarova-Trajkovska, J. Węsierska-Gądek, 2003, Journal of Cellular Biochemistry.

Compensatory expression of p73 in PARP-deficient mouse fibroblasts as response to a reduced level of regularly spliced wild-type p53 protein.

J. Węsierska‐Gądek, G. Schmid, Z. Wang, 1999, Biochemical and biophysical research communications.

Characterization of distinct consecutive phases in non-genotoxic p53-induced apoptosis of Ewing tumor cells and the rate-limiting role of caspase 8

H. Kovar, J. Węsierska‐Gądek, G. Schmid, 2000, Oncogene.

Increased cytotoxicity of an unusual DNA topoisomerase II inhibitor compound C-1305 toward HeLa cells with downregulated PARP-1 activity results from re-activation of the p53 pathway and modulation of mitotic checkpoints.

J. Węsierska‐Gądek, A. Składanowski, M. Sabisz, 2010, Biochemical pharmacology.

ADP-ribosylation of wild-type p53 in vitro: binding of p53 protein to specific p53 consensus sequence prevents its modification.

J. Węsierska‐Gądek, G. Schmid, C. Cerni, 1996, Biochemical and biophysical research communications.

Tubulohelical membrane arrays: From the initial observation to the elucidation of nanophysical properties and cellular function

Sebastian Wienerroither, S. Reipert, J. Węsierska-Gądek, 2010, PMC Biophysics.

Monitoring of Long‐Term Effects of Resveratrol on Cell Cycle Progression of Human HeLa Cells after Administration of a Single Dose

J. Węsierska‐Gądek, M. Kramer, J. Węsierska-Gądek, 2009, Annals of the New York Academy of Sciences.

Natural Compounds as Specific Inhibitors of Cyclin-Dependent Kinases – Past, Present and Future

J. Węsierska‐Gądek, O. Komina, M. Maurer, 2012 .

Functional p53 in cells contributes to the anticancer effect of the cyclin‐dependent kinase inhibitor roscovitine

J. Węsierska‐Gądek, M. Strnad, V. Kryštof, 2009, Journal of cellular biochemistry.

Cell cycle arrest induced in human breast cancer cells by cyclin-dependent kinase inhibitors: a comparison of the effects exerted by roscovitine and olomoucine.

J. Węsierska‐Gądek, M. Gueorguieva, M. Horký, 2004, Polish journal of pharmacology.

Role of PARP on iNOS pathway during endotoxin-induced acute lung injury

A. Goetz, C. Kupatt, R. Kiefmann, 2004, Intensive Care Medicine.

Tamoxifen enhances the anti-proliferative effect of roscovitine, a selective cyclin-dependent kinase inhibitor, on human ER-positive human breast cancer cells.

N. Zulehner, J. Węsierska-Gądek, Margarita Maurer, 2011, Journal of experimental therapeutics & oncology.

Impact of roscovitine, a selective CDK inhibitor, on cancer cells: bi-functionality increases its therapeutic potential.

J. Węsierska‐Gądek, O. Komina, M. Maurer, 2009, Acta biochimica Polonica.

Pleiotropic effects of selective CDK inhibitors on human normal and cancer cells.

B. Sarg, H. Lindner, J. Węsierska‐Gądek, 2008, Biochemical pharmacology.

R‐roscovitine (Seliciclib) affects CLL cells more strongly than combinations of fludarabine or cladribine with cyclophosphamide: Inhibition of CDK7 sensitizes leukemic cells to caspase‐dependent apoptosis

J. Węsierska‐Gądek, O. Komina, Z. Kiliańska, 2010, Journal of cellular biochemistry.

Platelet-endothelial cell interaction in pulmonary microcirculation: the role of PARS

A. Goetz, J. Węsierska‐Gądek, R. Kiefmann, 2004, Thrombosis and Haemostasis.

Interactions Between Ataxia Telangiectasia Mutated Kinase Inhibition, Poly(ADP-ribose) Polymerase-1 Inhibition and BRCA1 Status in Breast Cancer Cells

J. Węsierska‐Gądek, S. Heinzl, J. Węsierska-Gądek, 2014, Journal of cancer prevention.

PARP inhibition potentiates the cytotoxic activity of C-1305, a selective inhibitor of topoisomerase II, in human BRCA1-positive breast cancer cells☆

J. Węsierska‐Gądek, O. Komina, A. Składanowski, 2012, Biochemical pharmacology.

Reconstitution of human MCF‐7 breast cancer cells with caspase‐3 does not sensitize them to action of CDK inhibitors

J. Węsierska‐Gądek, O. Komina, M. Maurer, 2011, Journal of cellular biochemistry.

Is Olomoucine, a Weak CDK2 Inhibitor, Able to Induce Apoptosis in Cancer Cells?

J. Węsierska‐Gądek, S. Wandl, J. Węsierska-Gądek, 2009, Annals of the New York Academy of Sciences.

Why (multi)targeting of cyclin-dependent kinases is a promising therapeutic option for hormone-positive breast cancer and beyond.

J. Węsierska‐Gądek, Matthias Mauritz, J. Węsierska-Gądek, 2016, Future medicinal chemistry.

Therapeutic intervention by the simultaneous inhibition of DNA repair and type I or type II DNA topoisomerases: one strategy, many outcomes.

A. Składanowski, J. Węsierska-Gądek, 2012, Future medicinal chemistry.

Roscovitine‐activated HIP2 kinase induces phosphorylation of wt p53 at Ser‐46 in human MCF‐7 breast cancer cells

J. Węsierska‐Gądek, M. Schmitz, C. Ranftler, 2007, Journal of cellular biochemistry.

Physiological ageing: role of p53 and PARP-1 tumor suppressors in the regulation of terminal senescence.

J. Węsierska‐Gądek, G. Schmid, C. Ranftler, 2005, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

Interference with Estrogen Receptor-α by Dietary Components: Impact on the Balance Between Cell Proliferation and Cell Death

J. Węsierska‐Gądek, O. Komina, M. Maurer, 2012 .

Can ex vivo evaluation (testing) predict the sensitivity of CLL cells to therapy with purine analogs in conjunction with an alkylating agent? A comparison of in vivo and ex vivo responses to treatment

J. Węsierska‐Gądek, P. Smolewski, O. Komina, 2012, Medical Oncology.

Oncogenes do not Fully Override Cell-intrinsic Traits: Pronounced Impact of the Cellular Programme

J. Węsierska‐Gądek, G. Schmid, E. Walzi, 2009, Cancer Microenvironment.

Z. Kiliańska, M. Rogalińska, T. Robak, 2010, Journal of cellular biochemistry.

Roscovitine up‐regulates p53 protein and induces apoptosis in human HeLaS3 cervix carcinoma cells

M. Kramer, V. Kryštof, S. Wandl, 2008, Journal of cellular biochemistry.

A new multiplex assay allowing simultaneous detection of the inhibition of cell proliferation and induction of cell death

J. Węsierska‐Gądek, M. Gueorguieva, C. Ranftler, 2005, Journal of cellular biochemistry.

In vivo activated caspase‐3 cleaves PARP‐1 in rat liver after administration of the hepatocarcinogen N‐nitrosomorpholine (NNM) generating the 85 kDa fragment

J. Węsierska‐Gądek, M. Gueorguieva, J. Wojciechowski, 2004, Journal of cellular biochemistry.

Antinuclear antibodies in primary biliary cirrhosis.

J. Węsierska‐Gądek, C. Selmi, P. Invernizzi, 2005, Seminars in liver disease.

Action of a novel anticancer agent, CHS 828, on mouse fibroblasts: increased sensitivity of cells lacking poly (ADP-Ribose) polymerase-1.

J. Węsierska‐Gądek, R. Larsson, H. Lövborg, 2002, Cancer research.

Dual action of cyclin-dependent kinase inhibitors: induction of cell cycle arrest and apoptosis. A comparison of the effects exerted by roscovitine and cisplatin.

J. Węsierska‐Gądek, M. Gueorguieva, M. Horký, 2003, Polish journal of pharmacology.

Non‐apoptogenic killing of hela cervical carcinoma cells after short exposure to the alkylating agent N‐methyl‐N′‐nitro‐N‐nitrosoguanidine (MNNG)

J. Węsierska‐Gądek, M. Gueorguieva, M. Uhl, 2003, Journal of cellular biochemistry.

Reduced stability of regularly spliced but not alternatively spliced p53 protein in PARP-deficient mouse fibroblasts.

J. Węsierska‐Gądek, G. Schmid, Z. Wang, 1999, Cancer research.

Prevention of farnesylation of c‐Ha‐Ras protein enhances synergistically the cytotoxic action of doxorubicin in cycling but not in quiescent cells

J. Węsierska‐Gądek, G. Schmid, M. Kramer, 2006, Journal of cellular biochemistry.

5-FdUrd-araC heterodinucleoside re-establishes sensitivity in 5-FdUrd- and AraC-resistant MCF-7 breast cancer cells overexpressing ErbB2.

T. Szekeres, J. Węsierska‐Gądek, M. Gueorguieva, 2006, Differentiation; research in biological diversity.

Induction of cell cycle arrest and apoptosis in human cervix carcinoma cells during therapy by cisplatin.

J. Węsierska‐Gądek, M. Horký, V. Kotala, 2003, Cancer detection and prevention.

Autoantibodies against different histone H1 subtypes in systemic lupus erythematosus sera.

H. Lindner, J. Węsierska‐Gądek, E. Hitchman, 2010, Arthritis and rheumatism.

Nuclear Ras: Unexpected subcellular distribution of oncogenic forms

J. Węsierska‐Gądek, C. Cerni, W. Mosgoeller, 2001, Journal of cellular biochemistry. Supplement.

The effect of poly(ADP-ribose) on interactions of DNA with histones H1, H3 and H4.

J. Węsierska‐Gądek, G. Sauermann, J. Węsierska-Gądek, 1988, European journal of biochemistry.

Poly(ADP-ribose) effectively competes with DNA for histone H4 binding.

J. Węsierska‐Gądek, G. Sauermann, J. Węsierska-Gądek, 1986, Biochemical and biophysical research communications.